PTGX icon

Protagonist Therapeutics

136 hedge funds and large institutions have $1.22B invested in Protagonist Therapeutics in 2023 Q1 according to their latest regulatory filings, with 33 funds opening new positions, 44 increasing their positions, 44 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more funds holding in top 10

Funds holding in top 10:

more capital invested

Capital invested by funds: $ → $

more ownership

Funds ownership:

3% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 32

0% more funds holding

Funds holding: 136136 (0)

0% more repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 44

Holders
136
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$42.3M
Puts
$13.2M
Net Calls
Net Calls Change

Top Buyers

1 +$86.8M
2 +$41.2M
3 +$39.1M
4
RI
RTW Investments
New York
+$23.2M
5
PA
Perceptive Advisors
New York
+$22.2M
Name Holding Trade Value Shares
Change
Change in
Stake
76
$1.05M
77
$1.03M
78
$920K
79
$874K
80
$874K
81
$859K
82
$832K
83
$820K
84
$781K
85
$746K
86
$682K
87
$667K
88
$662K
89
$655K
90
$637K
91
$635K
92
$633K
93
$552K
94
$550K
95
$516K
96
$495K
97
$484K
98
$440K
99
$426K
100
$422K